Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
The Duke Lupus Registry is a research study aimed at understanding how lupus, a complex autoimmune disease, affects patients over time. Lupus can cause various symptoms like joint pain, rashes, and kidney issues, and it often occurs in younger women. In this study, researchers will collect health information and blood samples from patients diagnosed with either systemic lupus erythematosus or cutaneous lupus who are receiving care at the Duke Rheumatology clinics. The ultimate goal is to gather insights that can help improve treatment options for those living with lupus.
To participate in this study, you need to have a diagnosis of lupus and be a patient at Duke University Medical Center. Unfortunately, if you have trouble traveling to Duke for follow-up visits, cannot speak English, or are unable to give consent, you may not be eligible. If you join the study, you can expect to provide some information about your health and give a blood sample to help researchers learn more about lupus. Your participation could play an important role in enhancing our understanding and treatment of this challenging condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of Systemic Lupus Erythematosus or Cutaneous Lupus
- • Patient of a rheumatologist at Duke University Medical Center
- Exclusion Criteria:
- • Inability to travel to Duke for follow-up visits
- • Inability to speak English
- • Not able to provide informed consent
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Patients applied
Trial Officials
Megan E. B. Clowse, MD, MPH
Principal Investigator
Duke University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials